✦ LIBER ✦

Factors Affecting Drug Prescription in Patients With Stable COPD: Results From a Multicenter Spanish Study

✍ Scribed by J. de Miguel Díez; J.L. Izquierdo Alonso; J. Molina París; J.M. Bellón Cano; J.M. Rodríguez González-Moro; P. de Lucas Ramos

Book ID: 119628647
Publisher: Elsevier Science
Year: 2005
Tongue: Spanish
Weight: 313 KB
Volume: 41
Category: Article
ISSN: 0300-2896
DOI: 10.1016/s1579-2129(06)60399-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paediatric results from a multicenter, c

Paediatric results from a multicenter, cross-sectional, non-interventional surveillance study (aESCAPE study) to evaluate the adverse effects of antiepileptic drug treatment in patients with epilepsy

✍ B. Steinborn; S. Buyle; C. Baukens; P. Edrich; C. DeLa Loge 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 44 KB

The comparative one-year performance of

The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study

✍ Heiberg, Marte Schrumpf ;Koldingsnes, Wenche ;Mikkelsen, Knut ;Rødevand, Erik ;K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

TCT-420 Safety and Performance of the Ne

TCT-420 Safety and Performance of the Next Generation EnligHTN Renal Denervation System in Patients with Drug-resistant Hypertension: 12-Month Results From a First-in-Human Multicenter Study

✍ Worthley, Stephen G.; Webster, Mark W.; Montarello, Joseph; Antonis, Paul; Whitb 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Efficacy and safety of erlotinib HCl, an

Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study

✍ A.N. GORDON; N. FINKLER; R.P. EDWARDS; A.A. GARCIA; M. CROZIER; D.H. IRWIN; E. B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Ustekinumab in active psoriatic arthriti

Ustekinumab in active psoriatic arthritis including patients previously treated with anti–tumor necrosis factor agents: Week 24 results from PSUMMIT 2, a phase III, multicenter, double-blind, placebo-controlled study

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy and Safety Profile of Exenatide

Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study

✍ Inagaki, Nobuya; Atsumi, Yoshihito; Oura, Tomonori; Saito, Hitoshi; Imaoka, Take 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 962 KB